Business Context and Reporting Period
This Form 8-K reports on the 2016 Annual Meeting of Stockholders for Alnylam Pharmaceuticals, Inc., held on May 3, 2016. The report was filed on May 6, 2016. As of the record date of March 11, 2016, there were 85,355,302 shares of common stock issued and outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Director Elections: Stockholders re-elected three Class III directors to serve until the 2019 annual meeting:
- Steven M. Paul, M.D.: 69,348,665 votes for; 2,892,943 votes against.
- Amy W. Schulman: 70,925,597 votes for; 1,315,825 votes against.
- Kevin P. Starr: 69,319,567 votes for; 2,927,691 votes against.
- Executive Compensation: Stockholders approved the compensation of named executive officers in a non-binding advisory vote with 65,271,973 votes for and 6,957,004 votes against.
- Auditor Ratification: Stockholders ratified the appointment of PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending December 31, 2016, with 76,735,248 votes for and 324,156 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Important Facts for Investors to Verify
- Confirmation of the re-election of the three Class III directors and the specific vote counts indicating shareholder support levels.
- The outcome of the non-binding advisory vote on executive compensation, noting the significant number of votes cast against the proposal.
- Verification that PricewaterhouseCoopers LLP remains the independent auditor for the 2016 fiscal year.
- Review of the total broker non-votes (4,813,661) which were present for director elections but did not vote on the compensation or auditor proposals.